RaiseTheNorth

Genome British Columbia

Vancouver, BC
EarlySeedSpecter export (2026-11), owner approved after review

Investment Thesis

Genome BC is a non-profit that invests through its Industry Innovation (I²) Fund in early-stage British Columbia life science companies, including agritech and health startups. Its 2025 investments include $1.75M to Maia Farms and $1.5M to Verdi, with funding from provincial and federal governments and partners.

Focus Areas

Investment Stage
EarlySeed
Sectors
healthagrifoodforestryfisheriesaquacultureenvironment

Investment Signals

Check SizeC$1.5M
ProvincesBC
RoleBoth

Recent Deals

Sample Portfolio Companies

Renaissance BioScience

AUM & Sources

N/A
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →

Similar Funds

See incorrect information?

Help us keep this directory accurate and up to date.

Quick Stats
AUMN/A
HQVancouver, BC
CategoryN/A
StageEarlySeed
Check SizeC$1.5M
Leads RoundsLeads or follows
Last DealFeb 2026
Profile completeness
7 of 11 basic facts on record64%
Not published: assets under management, team, what sets them apart, a source for its AUM.
Profile updated
Report an Error